Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 114
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04209179 | A Clinical Study Investigating the Safety, Tolerability, PK and PD of PCO371 in Patients With Hypoparathyroidism | ||
| NCT05907980 | A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors | ||
| NCT00746317 | A Phase I Study of GC33 in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma) | ||
| NCT04963270 | A Study To Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia Gravis | ||
| NCT05494619 | A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Participants With Guillain-Barré Syndrome (GBS) | ||
| NCT00661284 | A Study of Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Development Code of Tocilizumab, an Anti IL-6 Receptor Monoclonal Antibody.) | ||
| NCT00470223 | Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma | ||
| NCT02475616 | A Single Ascending Dose Study of PCO371 in Healthy Volunteers | ||
| NCT07416604 | A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A | ||
| NCT05503264 | A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis | ||
| NCT02431117 | Non-drug Study to Assess the Suitability of Assessment Scales in Japanese Individuals With Down Syndrome Aged 6-30 | ||
| NCT02514681 | A Phase III Trial of Pertuzumab Retreatment in Previously Pertuzumab Treated Her2-Positive Advanced Breast Cancer | ||
| NCT06589986 | A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis | ||
| NCT00860639 | Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk | ||
| NCT00060138 | Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases | ||
| NCT04958265 | A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Participants With Atypical Hemolytic Uremic Syndrome (aHUS) | ||
| NCT00380601 | PhaseⅢOpen-label Study of MRA for Rheumatoid Arthritis(RA) | ||
| NCT07239336 | Study of DONQ52 in Active Celiac Disease | ||
| NCT00247663 | Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer | ||
| NCT00433888 | Switch and Maintenance Study of Intravenous Injections of R744 to Hemodialysis Patients (Phase Ⅲ Study) | ||
| NCT00447915 | Phase II/III Clinical Study of R484iv (Ibandronic Acid) for Primary Osteoporosis | ||
| NCT00779220 | A Study to Evaluate the Efficacy, Safety and Pharmacokinetics/Pharmacodynamics (PK/PD) of Ocrelizumab in Patients With Rheumatoid Arthritis | ||
| NCT05022927 | A Phase I Study of ERY974 in Patients With Hepatocellular Carcinoma | ||
| NCT00245414 | Trial of Pegasys® in Patients With Chronic Hepatitis C | ||
| NCT00144534 | Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA213JP | ||
| NCT02622321 | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors | ||
| NCT00144495 | A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy | ||
| NCT02748837 | A Study of ERY974 in Patient With Advanced Solid Tumors | ||
| NCT00144625 | Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA) | ||
| NCT06371417 | Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) | ||
| NCT00144547 | Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA012JP | ||
| NCT00433849 | Clinical Study of R744 to Peritoneal Dialysis Patients | ||
| NCT04338269 | A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment | ||
| NCT04501497 | Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2) | ||
| NCT00492427 | Clinical Study of R744 to Predialysis Patients( Phase III, Comparative Study in Comparison With Epoetin Beta) | ||
| NCT05269667 | A Study In Neuromyelitis Optica Spectrum Disorder (NMOSD) With Satralizumab As An Intervention | ||
| NCT01656525 | A Multiple-dose Study of Gantenerumab in Japanese Alzheimer&Apos;s Disease Patients | ||
| NCT02073279 | Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD) | ||
| NCT06793215 | A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer | ||
| NCT00433615 | Clinical Study of R744 to Predialysis Patients | ||
| NCT01989780 | Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer | ||
| NCT04818983 | The Biomarker Exploratory Study in Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2) | ||
| NCT05904886 | A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152) | ||
| NCT04846582 | An Observational Study of Patients With Endometriosis to Evaluate the Usefulness of the MEDL Score, a New Method for Evaluating Endometriosis Using MRI | ||
| NCT03726879 | A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer | ||
| NCT04861259 | A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS) | ||
| NCT00144599 | Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA) | ||
| NCT04732598 | A Phase III Study of Bevacizumab and Paclitaxel in Combination With Atezolizumab as a Treatment for Locally Advanced Unresectable or Metastatic Hormone Receptor-positive HER2 Negative Breast Cancer | ||
| NCT00345761 | Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer | ||
| NCT02965053 | A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis |
